## Summary table by gpt-4
Summary: 
The AI model suggested integrating recent technological advances, including genomic sequencing, artificial intelligence (AI), machine learning (ML), telemedicine, and wearable technology into personalized cancer care. The AI proposed using genomic sequencing to identify genetic mutations causing cancer in individual patients, creating personalized treatment plans targeting these mutations. Incorporation of AI and ML would analyze large data volumes from various diagnostic tests to recognize patterns and predict patient outcomes, aiding doctors in decision-making. Telemedicine allows remote patient care, offering virtual consultations, symptom monitoring, and digital personalized treatment plans delivery. Wearable devices could monitor symptoms and treatment responses, providing real-time data to adjust treatment plans and flag potential complications. The AI called for a phased execution, starting with genomic sequencing integration, followed by AI and ML integration, telemedicine, and wearable technology.

Main Ideas: 
- Integrating genomic sequencing to identify genetic mutations and create personalized treatment plans targeting these mutations.
- Harnessing AI and ML to analyze data from various diagnostic tests to identify patterns, predict patient outcomes and support treatment decisions.
- Utilization of Telemedicine for remote patient care, including virtual consultations, symptom monitoring, and delivery of personalized treatment plan.
- Employing wearable technology to monitor patient symptoms and treatment responses in real-time enabling the update of treatment plans and warning of potential complications.

Factual accuracy: 9
Problem Solving / Relevance: 9
Novelty / Creativity: 8
Specificity: 10
Feasibility: 7